QPharma Expands KOL Presence in Europe
24 May 2018 - 1:00PM
Business Wire
Titanium® Technology to Perform Influence
Mapping in 15 European Countries
QPharma, a premier provider of commercial and compliance
services to the life sciences industry, has been engaged by a major
European pharmaceutical client to perform Key Opinion Leader (KOL)
influence mapping.
The program will span 15 countries and multiple therapeutic
areas, representing a significant expansion of QPharma’s presence
in the KOL engagement industry in Europe. This builds on the
considerable momentum QPharma has built in the United States KOL
market, with numerous top life sciences companies added to its
client roster, and reaffirms the company’s position as an industry
leader.
Pharmaceutical companies routinely identify and engage with Key
Opinion Leaders, also known as thought leaders, to support
communication activities around their brands. KOLs are typically
physicians and other healthcare practitioners that are highly
influential within their fields. A pioneering force in thought
leader engagement and influence mapping, QPharma will deploy its Ti
KOL® solution, part of the Titanium® platform of commercial and
compliance tools.
In the execution of this program, QPharma will identify and
profile a Key Opinion Leader universe for the client, and the
company’s more than 300 medical research team members will analyze
and score KOLs using QPharma’s proprietary algorithms. A network
analysis will determine how KOLs are connected and how they
influence one another. This will result in a highly targeted
promotional plan that will enable the client to more effectively
message healthcare practitioners and promote its products.
“Our approach to KOL/HCP influence mapping to simultaneously
improve medical communications as well as enhance the effectiveness
of the field force has been recognized by the industry as
revolutionary,” said Badal Shah, Managing Director of KOL and
Targeting for QPharma. “Combined with the analytics and business
intelligence power of the Titanium suite, it represents the most
advanced thought leader engagement solution available on the
market.”
“QPharma has a longtime presence in Europe, having provided
commercial services, training, and compliance consulting to local
and global clients in numerous countries,” added QPharma President
and CEO Patrick P. Den Boer. “We look forward to continuing to
shape strategies for life sciences commercial effectiveness
throughout the region.”
The expansion coincides with QPharma’s plans to open an office
in Zurich, Switzerland to further solidify its presence in the
European Union. For more information, visit
www.qpharmacorp.com.
About QPharma, Inc.
Founded in 1994, QPharma is the industry leader in cloud-based
software and services for life
sciences. The Commercial Services division provides solutions that
include sample management and distribution, product launch
management, online training, and HCP/KOL targeting and engagement.
Services offered by the company’s Professional Services division
include validation services, project management, auditing, and
training. QPharma is a National Association of Boards of Pharmacy
Verified Accredited Wholesale Distributor, and an approved American
Medical Association Database Licensee.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180524005159/en/
QPharma, Inc.Brendan Middleton, 973-656-0011Director of
Marketing and PRbrendan.middleton@qpharmacorp.com